HTG Molecular Diagnostics to Announce Q2 2022 Financial Results and Host Conference Call on Thursday, August 11
HTG Molecular Diagnostics (Nasdaq: HTGM) will announce its financial results for Q2 2022 on August 11, 2022, following market close.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
HTG Molecular Diagnostics (Nasdaq: HTGM) will announce its financial results for Q2 2022 on August 11, 2022, following market close. A conference call is scheduled for 4:30 PM ET to discuss these results and present a corporate update. The call can be accessed via toll-free and international lines, and listeners can join the webcast through the provided link. HTG is focused on advancing precision medicine using its transcriptome-wide profiling technology, emphasizing its commitment to effective diagnostics and drug discovery.
Positive
- HTG's innovative transcriptome-wide profiling technology positions it strongly within the precision medicine sector.
- The scheduled conference call reflects transparency and engagement with investors regarding financial performance.
Negative
- None.
Details
News Market Reaction – HTGM
The recorded move for HTGM in the trading session of this news was +14.95%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
TUCSON, Ariz., Aug. 04, 2022 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling technology, today announced that it will report its financial results for the quarter ended June 30, 2022 after the market close on Thursday, August 11, 2022.
Management will also host a conference call with investors to discuss financial results and provide a corporate update at 4:30pm Eastern Time. Details for the conference call are as follows:
| Conference Call & Webcast Details | |
| Date: | Thursday, August 11 |
| Time: | 4:30pm ET |
| Toll Free: | 1-800-954-0602 |
| International: | 1-212-231-2936 |
| Conference ID: | 22019810 |
| Webcast: | https://viavid.webcasts.com/starthere.jsp?ei=1560944&tp_key=20e2ece390 |
About HTG:
HTG is accelerating precision medicine from diagnosis to treatment by harnessing the power of transcriptome-wide profiling to drive translational research, novel therapeutics and clinical diagnostics across a variety of disease areas.
Building on more than a decade of pioneering innovation and partnerships with biopharma leaders and major academic institutes, HTG’s proprietary RNA platform technologies are designed to make the development of life science tools and diagnostics more effective and efficient and to unlock a differentiated and disruptive approach to transformative drug discovery. For more information visit www.htgmolecular.com.
HTG Investor Contact:
Ashley Robinson
LifeSci Advisors
Phone: (617) 430-7577
Email: arr@lifesciadvisors.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.